March 14, 2018

Xconomy: Proxima Aims to Fill CRO Gap for Houston’s Growing Biotech Community

View All articles
Proxima Team

Our recent feature in Xconomy:

"Medical research is big business in Houston, but life science companies sometimes find they’re missing out on the clinical trial services typically provided by contract research organizations (CROs). Proxima Clinical Research wants to fill that gap, and the new company plans a more customer-focused approach to do it.

“We plan to implement ‘agile development’ into CROs,” says Pamela Kennedy, Proxima’s vice president of global business development. “We will offer a help desk. It will be by phone, e-mail, or in-person. A founder can just walk in and say, ‘I have this product.’ They don’t need an appointment.”
That approach, she says, differs from the typically more bureaucratic approach most CROs employ, she says. Another way the organization says it aims to stand apart from competitors is that Proxima will focus exclusively on early stage biotech and medical device companies.
Proxima, which will formally launch next month, was founded in December by Larry Lawson, a Houston-based medical device entrepreneur and GOOSE angel investor, and is located in JLabs @ TMC, next door to the Texas Medical Center’s Innovation Institute."

More Questions? We're here to help!